Alzheimer’s Disease

A drug that extends life span prevents Alzheimer’s deficits

April 12, 2010

If research results continue to be repeated and are turned into clinical trials, a drug already approved for some uses could be marshaled — sooner than we expect — to prevent Alzheimer’s disease in humans and improve health to the end of life.

Read more

Rapamycin rescues learning, memory in Alzheimer’s mouse model

February 24, 2010

Rapamycin, a drug that keeps the immune system from attacking transplanted organs, may have another exciting use: fighting Alzheimer’s disease.

Read more

Scientists: Protein that predicts Alzheimer’s also predicts HIV progression

June 17, 2008

A protein that is one of the major predictors of Alzheimer’s disease also predicts the pace at which HIV-infected persons will progress to death, San Antonio scientists reported this week.

Read more

March 29 ‘Spring Fling’ dinner/dance to benefit Alzheimer’s research

March 13, 2008

A “Spring Fling” dinner and dance later this month will raise funds for Alzheimer’s disease research at the Sam and Ann Barshop Institute for Longevity and Aging Studies.

Read more

San Antonio study examines investigational drug for Alzheimer’s

June 6, 2006

San Antonio residents diagnosed with Alzheimer’s disease may be eligible to participate in a clinical study offered by the Health Science Center. The study will assess whether an investigational drug, Flurizan, can slow Alzheimer’s progression.

Read more

Screening method identifies unfolded, aberrant proteins

February 21, 2006

During normal aging and various neurodegenerative diseases such as Alzheimer’s, Lou Gehrig’s and Parkinson’s diseases, proteins become unfolded or clump together, thereby losing their function and damaging the cells and tissues.

Read more